Month: October 2020

Glycyrrhizin alleviates Con A-induced hepatitis.

Glycyrrhizin alleviates Con A-induced hepatitis.

n/a PMID:  Biomed Pharmacother. 2019 Feb ;110:692-699. Epub 2018 Dec 12. PMID: 30553196 Abstract Title:  Glycyrrhizin alleviates Con A-induced hepatitis by differentially regulating the production of IL-17 and IL-25. Abstract:  Glycyrrhizin, a triterpenoid compound, has been reported to be an anti-inflammatory agent for the treatment of a variety of inflammatory diseases including hepatitis. However, the…

Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis.

Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis.

PMID:  Toxicol Appl Pharmacol. 2020 08 15 ;401:115101. Epub 2020 Jun 6. PMID: 32512072 Abstract Title:  Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats. Abstract:  Non-alcoholic steatohepatitis (NASH) is becoming of increasing significance due to its growing global prevalence and risk of progression to end-stage liver disease….

Close
Menu